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Abstract: The present research was designed to evaluate the hypoglycemic and 
hypolipidemic activity of ethyl acetate extract of Ficus mollis Vahl, Moraceae, against 
dexamethasone induced insulin resistance. Wistar albino rats were treated with 
dexamethasone (10 mg/kg) for ten days to induce insulin sensitivity. Hypoglycemic 
and hypolipidemic activity of ethyl acetate extract of F. mollis were evaluated by using 
two different doses (200 and 400 mg/kg body weight p.o.). The day 11 all rats were 
sacrifi ced and serum was collected for biochemical estimation, liver and pancreas were 
excised for histopathology. Administration of dexamethasone shows hyperglycemia 
and hyperlipidemia due to insulin resistance. Ethyl acetate extract of F. mollis reverted 
the hyperglycemia and hyperlipidemia caused by dexamethasone in a dose dependent 
manner. The changes were further confi rmed by histopathological report. The extract 
effect was compared with reference standard glibenclamide, which shows a similar 
effect. From these fi ndings it has been concluded that the ethyl acetate extract of Ficus 
mollis offered signifi cant protection against dexamethasone induced hyperglycemia and 
hyperlipidemia. 
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Introduction
 Diabetes is a global disease with a huge adverse 
effect on health and mortality, particularly diabetes is a 
major risk factor for cardiovascular disorders. Diabetes 
occurs at any time of life from infancy to old age. Type-2 
diabetes is primarily a lifestyle disorder. This accounts 
for around 90% of diabetes cases and increasing at an 
astonishing rate in developing countries like India. In 
1995, it has been estimated that around 135 million people 
had this condition, and this may increase to as many as 300 
million by the year 2025 (King et al., 1998).
 Liver is an important organ, which plays a 
pivotal role in glucose and lipid homeostasis and is 
severely affected during diabetes (Seifter & England, 
1982). During diabetes a profound alteration in the 
concentration and composition of lipid occurs (Sochar et 
al., 1995). Decreased glycolysis, impeded glycogenesis 
and increased gluconeogenesis are some of the changes of 
glucose metabolism occur in the diabetic liver. Diabetes 
mellitus is known to cause hyperlipidemia through various 
metabolic disarrangements. Among several metabolic 
disarrangements, insulin defi ciency has been known 
to stimulate lipolysis in the adipose tissue and give rise 
to hyperlipidemia and fatty liver. Thus, in diabetes 
hypercholesterolemia and hypertriglyceridemia often 
occur (Davis & Granner, 1996).
 Dexamethasone, a very potent and highly 
selective glucocorticoid used in the treatment 
of inflammatory disorders. Patients are using 
glucocorticoids as steroidal supplement, which 
profoundly affect carbohydrate and protein metabolism. 
Teleologically, these effects of glucocorticoids on 
intermediary metabolism can be viewed as protecting 
the glucose-dependent tissues (e.g., the brain and 
heart) from starvation. They stimulate the liver to 
form glucose from amino acids and glycerol and to 
store glucose as glycogen in the liver. In the periphery 
tissue, glucocorticoids diminish glucose utilization, 
increase protein breakdown by increasing the synthesis 
of glutamine and lipolysis, thereby providing amino 
acids and glycerol for gluconeogenesis. The net result 
is to increase blood glucose levels. Glucocorticoids 
can worsen glycemic control in patients with overt 
diabetes and can precipitate the onset of hyperglycemia 
in patients who are otherwise predisposed (Bernard et 
al., 2006).
 Ficus mollis Vahl synonym: Ficus tomentosa 
(Roxb) belongs to family Moraceae is the large tree 
distributed in rocky, hilly and dry lands (Madhava 
Chetty et al., 2008). The genus is remarkable for 
the large variation in the habits of its species. Ficus 
mollis used for a variety of diseases in traditional 
medicine. The leaves of F. mollis along with leaves of 
Madhuca indica were used to relieve the pain in the 
ear (Venkataramana & Venkataraju, 2004). Alcoholic 
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extracts of leaves and bark of Ficus mollis shown good 
antibacterial activity (Sreenivasulu et al., 2009). The 
present research was made to investigate the potential 
hypoglycemic and hypolipidemic effect of Ficus mollis 
in dexamethasone-induced insulin resistance in rats.
Materials and Methods
Collection and identification of plant
 The leaves of Ficus mollis Vahl, Moraceae, 
were collected from Talakona forest, Chittor Dist, Andhra 
Pradesh in the month of June, 2007 and identified by Dr. K. 
Madhava Chetty, Department of Botany, Sri Venkateswara 
University, Tirupathi. The voucher specimen (ANCP-MP-
89) has been deposited in the parent department.
Animals
 Wistar albino rats (175-200 g) of both male and 
female were obtained from the Institute Animal House 
and maintained at 25±2 °C temperature and relative 
humidity 45-55% under 12:12 h light:dark cycle. Rats 
were fed with standard rat chow and water ad-libitum. 
The protocol was approved by the Institute's Animal 
Ethical Committee (1220/a/08/CPCSEA).
Preparation of the plant extract
 About 150 g of dried leaves of F. mollis were 
taken in a 5000 mL of the round bottom flask and extracted 
for 72 h by a continuous hot percolation process using 
different solvents according to the increasing polarity; 
likewise pet ether, benzene, chloroform, acetone, ethyl 
acetate, methanol, ethanol, water. The extracts were 
filtered through the Whatmann filter paper to remove 
impurities. The extracts were then concentrated by vacuum 
distillation, cooled and placed in desiccators to remove the 
excessive moisture.
Phytochemical analysis
 The concentrated extracts were subjected to 
chemical test as per the methods mentioned in the reference 
book for the identification of the various constituents 
(Harborne, 1998). 
Acute toxicity studies
 Ethyl acetate extract of F. mollis was 
administered orally through gastric intubation in 5% 
Tween-80 (T80) used as a surfactant at doses of 500, 
1000, 1500, 2000 and 3000 mg/kg bw and control group 
received 0.5 mL of 5% T80. The animals were observed 
continuously for 72 h for any signs of behavioral 
changes, toxicity and mortality.
Dexamethasone induced hyperglycemia and 
hyperlipidemia
 Animals were divided into five groups, each 
consisting of six rats. Rats in the first group received vehicle 
and served as a control group, while the second group of 
rats received vehicle plus dexamethasone (10 mg/kg s.c.) 
and served as a positive control group. Rats in experimental 
groups 3 were treated with glibenclamide (500 μg/mg p.o.) 
plus dexamethasone, whereas rats in the 4th and 5th group 
were treated with ethyl acetate extract of F. mollis (200 
and 400 mg/kg p.o., dose selected from acute toxicity 
studies) plus dexamethasone. All the animals received 
their respective assigned treatment daily for a period of 
ten days. Rats of group 2-5 were daily fasted over night 
before dexamethasone treatment. On day 11, the animals 
were anesthetized with ether, and blood was collected 
from retro orbital plexus. Serum was then separated for the 
estimation of glucose, cholesterol, triacylglyceride, high 
density lipoprotein (HDL) and low density lipoprotein 
(LDL) along with transaminases (SGOT, SGPT) by using 
respective kits purchased from Span Diagnostics, Pune.
Statistics 
 All the results were expressed as mean±SEM, and 
the data were analyzed using one way ANOVA followed 
by Student newman keuls post test using GraphPad Prism 
software p<0.05 was considered significant. 
Results
Phytochemical tests
 Various phytochemical tests were performed 
for the pet ether, chloroform and ethyl acetate extract 
of F. mollis. The phytochemical evaluations showed the 
presence of triterpenoids and flavonoids in ethyl acetate 
extract.
Acute toxicity study
 There was no mortality or any signs of behavioral 
changes or toxicity observed after oral administration of 
ethyl acetate extract of F. mollis up to the dose level of 
3000 mg/kg bw in rats. 
Dexamethasone induced hyperglycemia and 
hyperlipidemia
 There is significant (p<0.01) increase in the level 
of Glucose, cholesterol, LDL, triacylglycerides, SGOT, 
SGPT and significant (p<0.05) decrease in the level of 
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HDL in dexamethasone induced rats when compared 
with vehicle treated rats. Ethyl acetate extract of F. mollis 
significantly (p<0.01 and p<0.05) decreased the level of 
glucose, cholesterol, LDL, triacylglycerides, SGOT, SGPT 
and significantly (p<0.01 and p<0.05) increased the level of 
HDL in two different doses. There are significant changes 
in the level of glucose, cholesterol, triacylglycerides, 
SGOT, and SGPT in glibenclamide treated rats (Table 1). 
 The liver of the rats treated with saline showing 
the normal architecture of the hepatocytes (Figure 1a). 
The liver of the rats treated with dexamethasone showing 
degeneration of hepatic cords and inflammation (Figure 
1b). The liver of the rats treated with glibenclamide 
showing the normal architecture of the rats hepatocytes 
without inflammation (Figure 1c). The liver of the 
rats treated with F. mollis showing the regeneration 
of hepatic cords with minimal inflammation (Figure 
1d,e). Rat pancreas treated with saline showing normal 
parenchymatous cell without any degeneration and 
inflammation (Figure 2a). Rat pancreas treated with 
dexamethasone showing degeneration pancreatic cells 
and with inflammation vacuoles (Figure 2b). Rat pancreas 
treated with glibenclamide showing mild changes in 
the cells of the pancreas without inflammation (Figure 
2c). Rat pancreas treated with F. mollis does not show 
a marked inflammation collection in the pancreatic cells 
(Figure 2d,e).
Table 1. Effect of Ficus mollis extract on dexamethasone induced hyperglycemia and hyperlipidemia.
Group Glucose mg/dL
Cholesterol 
mmol/L
HDL 
mmol/L
LDL 
mmol/L
Triacylglyceride 
mmol/L
SGOT 
IU/L
SGPT 
IU/L
G1 97.5±0.5 67.5±0.5 23±2 35±0 61±1 203±1 82.5± 0.5
G2 172±2** 129±3** 15.5±0.5* 44.5±1.5* 99.5±0.5** 475±5.5** 177.5±1.5**
G3 137±5a 77.5±0.5a 18.5±0.5ns 39.5±0.5ns 81.5±1.5ns 226.5±0.5a 90.5±0.5b
G4 147.5± 5.5b 81±1a 22.5±0.5b 43.5±2.5ns 82±11ns 269± 9a 94.5±.5b
G5 123.5± 7.5a 88±8a 16.5±0.5ns 37.5±2.5ns 63.5±2.5b 305±6.5a 77.5±0.5b
All values are expressed as mean±SEM. One way ANOVA followed by Dunnet’s post test. *p<0.05; **p<0.01 Vs C. ap<0.05; bp<0.01 Vs NC. ns: non 
specific; G1: control group treated with saline; G2: negative control group which is treated with dexamethasone; G3: positive control group which is 
treated with dexamethasone and Glibenclamide; G4: ethyl acetate extract of Ficus mollis (200 mg/kg) treated animal group; G5: ethyl acetate extract 
of Ficus mollis (400 mg/kg) treated animal group.
Figure 1. Histopathology of liver. A. The liver of the rats treated with saline; B. The liver of the rats treated with dexamethasone; C. 
The liver of the rats treated with glibenclamide; D. The liver of the rats treated with Ficus mollis (200 mg/kg); E. The liver of the rats 
treated with F. mollis (400 mg/kg).
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Discussion
 Insulin resistance in type-2 diabetes is not only 
associated with hyperglycemia but also with hyperlipidemia 
and atherosclerosis (DeFronzo et al., 1992; Reaven,1988). 
Insulin resistance in humans has been shown to be present 
in conditions like Non Insulin Dependant Diabetes Mellitus 
(NIDDM), obesity and dyslipidemia. Thus interventions to 
decrease insulin resistance may postpone the development 
of NIDDM and its complications. By treatment with 
natural herbs we may find lesser side effects compared to 
the presently used synthetic oral antidiabetic agents.
 In the present study it was found that the 
elevation of serum glucose and abnormal changes in the 
lipid profile in dexamethasone treated rats showed the 
hyperglycemia and hyperlipidemia caused by this drug. 
Dexamethasone increases triacylglyceride levels, caused 
an imbalance in lipid metabolism leading to hyperlipidemia 
(Wiesenberg et al., 1998) and an increase in glucose 
levels leading to hyperglycemia (Mahendran & Devi, 
2001). Pharmacological doses of glucocorticoids induce 
the gene expression in rat adipocyte tissue within 24 h. 
This is followed by complex metabolic changes resulting 
in a decrease in food consumption; reduction in body 
weight, profound obesity often accompanied by diabetes 
and the development of insulin resistance with enhanced 
blood glucose and triacylglyceride levels. Ethyl acetate 
extract of F. mollis prevented the rise in triacylglyceride, 
glucose, cholesterol and LDL caused by dexamethasone. 
Further, this also prevented the progressive decrease in 
HDL and body weight caused by dexamethasone. The 
phytochemical screening shows the presence of flavonoids 
and triterpenoids in all the extract. The concentration of 
flavonoids is more in the ethyl acetate extract which might 
be a responsible active principle for these effects.
Conclusion
 The ethyl acetate extract of Ficus mollis gave 
the positive result to the flavonoids and triterpenoids in 
phytochemical studies. The flavonoids present in the 
Ficus mollis leaves may be responsible for hypoglycemic 
Figure 2. Histopathology of pancreas. A. The liver of the rats treated with saline; B. The liver of the rats treated with dexamethasone; 
C. The liver of the rats treated with glibenclamide; D. The liver of the rats treated with Ficus mollis (200 mg/kg); E. The liver of the 
rats treated with F. mollis (400 mg/kg).
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and hypolipidemic activity. Two different doses of ethyl 
acetate extract were selected for the acute toxicity studies 
is 200 and 400mg/kg. Among the two, 200 mg/kg dose 
has shown better results than the 400 mg/kg. At 400mg/kg 
dose the animals shown little toxicity and minor damage in 
the pancreatic cells. 
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